Theodore Daniel Zucconi - Net Worth and Insider Trading

Theodore Daniel Zucconi Net Worth

The estimated net worth of Theodore Daniel Zucconi is at least $3,563 dollars as of 2024-04-25. Theodore Daniel Zucconi is the Director of Galectin Therapeutics Inc and owns about 1,083 shares of Galectin Therapeutics Inc (GALT) stock worth over $3,563. Details can be seen in Theodore Daniel Zucconi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Theodore Daniel Zucconi has not made any transactions after 2018-04-16 and currently still holds the listed stock(s).

Transaction Summary of Theodore Daniel Zucconi

To

Theodore Daniel Zucconi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Theodore Daniel Zucconi owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of Theodore Daniel Zucconi’s form 4 insider trades.

Insider Ownership Summary of Theodore Daniel Zucconi

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2018-04-16 director

Theodore Daniel Zucconi Latest Holdings Summary

Theodore Daniel Zucconi currently owns a total of 1 stock. Theodore Daniel Zucconi owns 1,083 shares of Galectin Therapeutics Inc (GALT) as of April 16, 2018, with a value of $3,563.

Latest Holdings of Theodore Daniel Zucconi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2018-04-16 1,083 3.29 3,563

Holding Weightings of Theodore Daniel Zucconi


Theodore Daniel Zucconi Form 4 Trading Tracker

According to the SEC Form 4 filings, Theodore Daniel Zucconi has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the sale of 4,000 shares on April 16, 2018, which brought Theodore Daniel Zucconi around $14,320.

Insider Trading History of Theodore Daniel Zucconi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Theodore Daniel Zucconi Trading Performance

GuruFocus tracks the stock performance after each of Theodore Daniel Zucconi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Theodore Daniel Zucconi is -26.5%. GuruFocus also compares Theodore Daniel Zucconi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Theodore Daniel Zucconi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Theodore Daniel Zucconi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Theodore Daniel Zucconi

Average Return

73.5%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.13 -26.5 13.25 73.5 30.91 10.42
Relative Return to S&P 500(%) 3.47 -28.4 4.97 59.54 22.43 3.21

Theodore Daniel Zucconi Ownership Network

Ownership Network List of Theodore Daniel Zucconi

No Data

Ownership Network Relation of Theodore Daniel Zucconi


Theodore Daniel Zucconi Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Theodore Daniel Zucconi is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Theodore Daniel Zucconi made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , and a net purchase of 12,500 shares made by Kevin D Freeman .

In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Galectin Therapeutics Inc (GALT) were sold and 15,898 shares were bought by its insiders, resulting in a net purchase of 15,898 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Theodore Daniel Zucconi Mailing Address

Above is the net worth, insider trading, and ownership report for Theodore Daniel Zucconi. You might contact Theodore Daniel Zucconi via mailing address: Pro-pharmaceuticals Inc, 7 Wells Avenue Suite 34, Newton Ma 02459.

Discussions on Theodore Daniel Zucconi

No discussions yet.